Self-Collection and Molecular Diagnosis for Detection of Human Papillomavirus: Why Incorporate It?
Autor: | Inês Aparecida Tozetti, Larissa Zatorre Almeida-Lugo, Vanessa Terezinha Gubert de Matos, Camila Mareti Bonin-Jacob |
---|---|
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Colposcopy Cervical cancer medicine.medical_specialty medicine.diagnostic_test business.industry 030106 microbiology Cancer Self collection medicine.disease Triage 03 medical and health sciences 0302 clinical medicine Infectious Diseases Health care Medicine 030212 general & internal medicine Human papillomavirus business Intensive care medicine Cause of death |
Zdroj: | Current Infectious Disease Reports. 21 |
ISSN: | 1534-3146 1523-3847 |
Popis: | Purpose of review Cervical cancer, the third cause of death by cancer among Brazil's women, is associated with human papillomavirus (HPV) infection. In some countries of South America, North America, Europe, and Oceania, initial screening for HPV DNA and subsequent follow-up with HPV-positive patients using colposcopy and cytological testing are used as preventative measures. Recent findings For HPV DNA detection, it is necessary to obtain cervical cells by conventional clinical collection method or self-collection of the cells that flake off from the uterine cervix and vaginal canal. Self-collection has been shown to be a viable option for obtaining samples and is a less invasive method that is more accepted by women. Thus, it can potentially decrease the limitations of the conventional clinical collection methods. The efficiency of the self-collection method aligned with the implementation of HPV molecular testing, if adopted by public and private health care systems, may extend the reach of current cervical cancer prevention efforts. In addition, considering all phases from triage to treatment, this method may reduce health care costs and the time spent by patients and health care teams to conduct examinations and collect samples. |
Databáze: | OpenAIRE |
Externí odkaz: |